Literature DB >> 10683304

Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain.

D M Yurek1, A Fletcher-Turner.   

Abstract

Young (4-5 month old) and old (32-34 month old) Brown Norway/F344 hybrid rats were given unilateral 6-OHDA lesions of the nigrostriatal pathway. Four weeks later tissue from the lesioned or intact striatum or ventral midbrain was dissected and analyzed for brain-derived neurotrophic factor (BDNF) protein levels using an enzyme-linked immunosorbent assay. BDNF protein content was greater in the lesioned striatum than in the intact striatum for all young rats, and the increased BDNF content in the lesioned striatum of young rats was directly correlated with severity of lesion as determined by rotational scores. BDNF content in the lesioned striatum increased in less than half of the old rats and was not significantly different than BDNF content in the intact striatum. BDNF content in the lesioned substantia nigra/ventral tegmental area (SN/VTA) was greater than BDNF content in the intact SN/VTA for both young and old rats. These data suggest that an age-related difference in activity of at least one neurotrophic factor, BDNF, occur within the denervated striatum following a neurotoxic lesion of the nigrostriatal pathway. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683304     DOI: 10.1006/exnr.1999.7274

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  20 in total

1.  Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging.

Authors:  H A Boger; P Mannangatti; D J Samuvel; A J Saylor; T S Bender; J F McGinty; A M Fortress; V Zaman; P Huang; L D Middaugh; P K Randall; L D Jayanthi; B Rohrer; K L Helke; A-C Granholm; S Ramamoorthy
Journal:  Genes Brain Behav       Date:  2010-10-19       Impact factor: 3.449

2.  Lesion size-dependent synaptic and astrocytic responses in cortex contralateral to infarcts in middle-aged rats.

Authors:  Soo Young Kim; Theresa A Jones
Journal:  Synapse       Date:  2010-09       Impact factor: 2.562

3.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 4.  Cell therapy in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  NeuroRx       Date:  2004-10

5.  Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration.

Authors:  D Kirik; C Winkler; A Björklund
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

6.  Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system.

Authors:  Katrina L Paumier; Caryl E Sortwell; Lalitha Madhavan; Brian Terpstra; Brian F Daley; Timothy J Collier
Journal:  Exp Neurol       Date:  2015-02-12       Impact factor: 5.330

Review 7.  Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan.

Authors:  S M Rothman; M P Mattson
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

8.  Strain difference in the up-regulation of FGF-2 protein following a neurotoxic lesion of the nigrostriatal pathway.

Authors:  David M Yurek; Anita M Fletcher; Laura E Peters; Wayne A Cass
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

Review 9.  A dual-hit animal model for age-related parkinsonism.

Authors:  Heather A Boger; Ann-Charlotte Granholm; Jacqueline F McGinty; Lawrence D Middaugh
Journal:  Prog Neurobiol       Date:  2009-10-21       Impact factor: 11.685

10.  Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats.

Authors:  J W Dickerson; A M Hemmerle; S Numan; K H Lundgren; K B Seroogy
Journal:  Neuroscience       Date:  2009-06-06       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.